Page results
-
This page provides information about the thermoregulatory sweat test (TST).
-
Taking care of yourself before and during cancer treatment can make a big difference. It can help reduce treatment side effects and make you feel stronger, both physically and emotionally. It can also help you feel more in control of what's happening.
-
Information about activating your MyCare UCLH app.
-
The diagnostic haematology clinics at UCLH perform comprehensive blood testing, including blood film examination, immunophenotyping and molecular testing.
-
Information about the Integrated General Medicine Service at the RLHIM patient information leaflet.
-
This page provides information about post procedural care following a diagnostic angiogram or endovascular treatment and possible complications that may occur. It is intended for use by patients (or their families or carers) who have had a diagnostic angiogram or endovascular treatment in the angiography suite at NHNN. If you have any questions about this a member of the Neuroradiology team will be happy to answer them for you
-
Our new report shows the difference charitable funds can make to patients, staff and research at UCLH
-
The UCLH Maternity Voices Partnership (MVP) is a team of women and their families, commissioners and providers (midwives and doctors) working together to review and contribute to the development of local maternity care.
-
This page is for parents and carers whose child is having radiotherapy treatment to a limb (arm or leg).
-
The service includes diagnosis, quantifying the degree of hearing loss, and rehabilitation of hearing impairment to limit participation restriction.
File results
-
FOI/2024/0112 - Fertility treatment in 2021
-
FOI/2024/0116 - Patient treatment due to noise levels of the London Underground
-
FOI/2024/0121 - Migraine treatments
-
FOI/2024/0126 - Ophthalmology RTT pathway
-
FOI/2024/0128 - Post mortem cardiac device interrogation
-
FOI/2024/0129 - Nursing associate and anaesthesia associate staffing
-
FOI/2024/0131 - Alpha-1 Proteinase-Inhibitor (AAT) purchased in 2023
-
FOI/2024/0132 - Cancer patients diagnosed in A&E
-
FOI/2024/0133 - Non-Emergency Patient Transport Services (NEPTS)
-
FOI/2024/0134 - Joint infection services for paediatric/ adult patients